ICAM1 and diabetes mellitus: Several studieshave reported increased plasma levels of E-selectin and ICAM-1 in patients withhypertension, diabetes, and hypercholesterolemia [25–27, 34]; moreover in patients at cardiovascular risk, plasma concentration of ICAM-1 canpredict adverse outcome [28].